Plasma levels of vitamins A and E, coenzyme Q10, and anti-ox-LDL antibody titer in children treated with an elimination diet due to food hypersensitivity.
OBJECTIVE
Has elimination diet applied in children with food hypersensitivity in infancy any effect on plasma levels of anti-oxidative vitamins and antibodies to oxidized low-density lipoprotein (anti-ox-LDL antibody) titer in these children at their pre-school age?"


METHODS
The study involved 92 children (3 to 7 years of age) with food hypersensitivity treated in their infancy and early childhood with soy formula or casein hydrolysate, as a milk substitute for at least 12 months. Control group comprised 62 children, who had never been treated with an elimination diet.


METHODS
The status of the anti-oxidative system was evaluated by determination of retinol, alpha-tocopherol, and coenzyme Q10 plasma levels by high-performance liquid chromatography (HPLC). The titer of antibodies to oxidized LDL lipoproteins was specified by immunoenzymatic assay. On the basis of the RESULTS, the following CONCLUSIONS have been reached: 1. It was shown that alpha-tocopherol and retinol levels in pre-school children who had received dietary treatment in their infancy, were higher than in the control group. No deficiencies in anti-oxidative vitamins within the control group were found. 2. A type of milk-substitute formula applied in the elimination diet had no effect on the status of the anti-oxidative system in the children examined.
Department of Paediatrics and Developmental Disorders in Children and Adolescents, Medical University in Bialystok, Poland. radek@hoga.pl
Bozena
B
Mikoluc
Radoslaw
R
Motkowski
Joanna
J
Karpinska
Janina
J
Piotrowska-Jastrzebska
D000906:Antibodies / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005512:Food Hypersensitivity / Q000178:diet therapy*; D006801:Humans; D008077:Lipoproteins, LDL / Q000276:immunology*; D008297:Male; D041941:Milk Substitutes / Q000008:administration & dosage*; D011897:Random Allocation; D012189:Retrospective Studies; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000097:blood; D014801:Vitamin A / Q000097:blood*; D024502:alpha-Tocopherol / Q000097:blood*
D000906:Antibodies; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D014801:Vitamin A; D014451:Ubiquinone; C024989:coenzyme Q10; D024502:alpha-Tocopherol